Busan, South Korea

Mi Young Cho

This inventor holds 1 USPTO granted patent. Top assignee: Samyang Genex Corporation. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mi Young Cho. Retrieved from https://idiyas.com/inventor/mi-young-cho-gbxj0c2n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mi Young Cho: Innovator in Protein Encapsulation

Introduction

Mi Young Cho is a prominent inventor based in Pusan, South Korea. She has made significant contributions to the field of biotechnology, particularly in the area of protein encapsulation. Her innovative work has the potential to impact various applications in immune response and therapeutic development.

Latest Patents

Mi Young Cho holds a patent titled "Proteins related to encapsulation and genes encoding the same." This invention pertains to a protein that plays a crucial role in encapsulation during immune reactions, along with the gene that encodes this protein. This patent highlights her expertise and dedication to advancing scientific knowledge in her field. She has 1 patent to her name.

Career Highlights

Throughout her career, Mi Young Cho has been associated with Samyang Genex Corporation, where she has been able to apply her research and innovations effectively. Her work at the company has allowed her to collaborate with other talented professionals in the industry.

Collaborations

Some of her notable coworkers include Bok Luel Lee and Chong Jin Park. Their collaborative efforts contribute to the advancement of research and development in their respective fields.

Conclusion

Mi Young Cho is a remarkable inventor whose work in protein encapsulation is paving the way for future innovations in biotechnology. Her contributions are essential for the ongoing development of therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…